Agilent Technologies Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Direxion Daily Semiconductor Bear 3X Shares trades at $43.1. The key difference: Agilent Technologies Inc pays a 0.69% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals.
| A | SOXS | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $157.20 | $1.49K |
52-Week Low | $110.24 | $32.50 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $42.08, down 6.18% over 24 hours amid a bearish technical signal. Recent news highlights its inverse leverage benefiting from semiconductor sector weakness, with a 1:10 stock split scheduled for July 2026. Technical indicators show oversold conditions with an RSI of 8.06, while support sits at $40.
The outlook remains risky due to its leveraged inverse structure, which amplifies losses if semiconductor stocks rebound. Opportunities exist for short-term traders betting on continued chip sector declines, but long-term holders face decay and volatility risks. Key risks include AI-driven semiconductor rallies and macroeconomic shifts affecting tech demand.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →